Advertisement

Topics

Microsaic's Technology Breakthrough Demonstrates Cost and Time Savings in the Manufacture of Biologics

05:38 EDT 14 Jun 2019 | Lab Bulletin

microsaic technology biologicsMicrosaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, has developed proof of concept workflows to analyse in real-time complex samples from bioreactors, which could enable customers to achieve significant costs and time savings. An independent laboratory was engaged to compare the use of Microsaic's MiD® ProteinID technology as an in-situ technique for measuring small and large molecules....

Original Article: Microsaic's Technology Breakthrough Demonstrates Cost and Time Savings in the Manufacture of Biologics

NEXT ARTICLE

More From BioPortfolio on "Microsaic's Technology Breakthrough Demonstrates Cost and Time Savings in the Manufacture of Biologics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Multiple Sclerosis MS
Multiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK. The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...